1.
Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial
by The AVERT Trial Collaboration group
The Lancet (British edition), 2015, Vol.386 (9988), p.46-55
2.
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomi...
by Mohr, Friedrich W, Prof
The Lancet (British edition), 2013, Vol.381 (9867), p.629-638
3.
Insights into epiretinal membranes: presence of ectopic inner foveal layers and a new optical coherence tomography staging scheme
by Govetto, Andrea
American journal of ophthalmology, 2016, Vol.175, p.99-113
4.
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
by Iadecola, Costantino
Hypertension (Dallas, Tex. 1979), 2016-12, Vol.68 (6), p.e67-e94
5.
Congenital adrenal hyperplasia
by El-Maouche, Diala, MD
The Lancet (British edition), 2017, Vol.390 (10108), p.2194-2210
6.
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and trea...
by Lawitz, Eric, Prof
The Lancet (British edition), 2014, Vol.384 (9956), p.1756-1765
7.
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
by Marcellin, Patrick, Prof
The Lancet (British edition), 2013, Vol.381 (9865), p.468-475
8.
Treatment of acute postoperative pain
by Wu, Christopher L, Prof
The Lancet (British edition), 2011, Vol.377 (9784), p.2215-2225
9.
Estimating Optical Coherence Tomography Structural Measurement Floors to Improve Detection of Progression in Advanced Glaucoma
by Bowd, Christopher
American journal of ophthalmology, 2017-03, Vol.175, p.37-44
10.
Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial
by Shahzad, Adeel, MRCP
The Lancet (British edition), 2014, Vol.384 (9957), p.1849-1858
11.
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
by Hanania, Nicola A
Thorax, 2015-08, Vol.70 (8), p.748-756
12.
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
by Vande Casteele, Niels
Gut, 2015-10, Vol.64 (10), p.1539-1545
13.
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomise...
by Burmester, Gerd R, Prof
The Lancet (British edition), 2013, Vol.381 (9865), p.451-460
14.
Prolonged remission in Caucasian patients with SLE: prevalence and outcomes
by Zen, Margherita
Annals of the rheumatic diseases, 2015-12, Vol.74 (12), p.2117-2122
15.
Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period
by Jones, Ian, Prof
The Lancet (British edition), 2014, Vol.384 (9956), p.1789-1799
16.
Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer
by Ruel, Ewa
The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1529-1536
17.
Cam impingement causes osteoarthritis of the hip: a nationwide prospective cohort study (CHECK)
by Agricola, Rintje
Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.918-923
18.
Exacerbation risk and characterisation of the UK’s asthma population from infants to old age
by Bloom, Chloe I
Thorax, 2018-04, Vol.73 (4), p.313-320
19.
Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer
by Miyamoto, Yuji
Annals of surgical oncology, 2015-01-07, Vol.22 (8), p.2663-2668
20.
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
by van Rhee, Frits, Prof
The lancet oncology, 2014, Vol.15 (9), p.966-974
Filter electronic articles 3.709 Hits
Remove Filters
- Subjects
- Follow-Up Studies
- Severity Of Illness Index (3.706)
- Humans (3.700)
- more ...